Sofinnova Investments have been funding futures since 1974. Their mission is to improve the lives of patients through science. They strive to provide outstanding results for who they serve which includes patients, entrepreneurs, and investors. They are considered a clinical-stage biopharmaceutical investment firm.
They have approximately $2.1B in assets, and they invest in both private and public equity of therapeutics-focused companies. Sofinnova has invested in many companies in the U.S. and in Europe. They have locations in Menlo Park, CA, La Jolla, CA, and Montreal, Quebec. Their investment team consists of doctors and doctorate holders.